According to the Crystal Integration announcement, the total number of H shares sold by the company globally is 216 million, of which the Hong Kong public sale accounts for 10% and the international sale accounts for 90%. Based on the offering price of HK$32.30 per share, after deducting related expenses, assuming that the over-allotment rights were not exercised, the net proceeds would be approximately HK$6.779 billion. On July 10, 2026, these H shares were listed and traded on the main board of the Hong Kong Stock Exchange. Prior to this offering and listing, the total share capital of the company was 2,08 billion shares. After issuance, if the over-allotment rights are not exercised, the total share capital is 2,224 billion shares; if all are exercised, it is 2,256 billion shares. The shareholding ratio of shareholders holding 5% or more of the shares is diluted accordingly.

According to the Crystal Integration announcement, the total number of H shares sold by the company globally is 216 million, of which the Hong Kong public sale accounts for 10% and the international sale accounts for 90%. Based on the offering price of HK$32.30 per share, after deducting related expenses, assuming that the over-allotment rights were not exercised, the net proceeds would be approximately HK$6.779 billion. On July 10, 2026, these H shares were listed and traded on the main board of the Hong Kong Stock Exchange. Prior to this offering and listing, the total share capital of the company was 2,08 billion shares. After issuance, if the over-allotment rights are not exercised, the total share capital is 2,224 billion shares; if all are exercised, it is 2,256 billion shares. The shareholding ratio of shareholders holding 5% or more of the shares is diluted accordingly.